Foghorn Therapeutics Statistics
Total Valuation
FHTX has a market cap or net worth of $250.71 million. The enterprise value is $109.07 million.
Important Dates
The last earnings date was Thursday, May 7, 2026, before market open.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
FHTX has 58.71 million shares outstanding. The number of shares has increased by 7.75% in one year.
| Current Share Class | 58.71M |
| Shares Outstanding | 58.71M |
| Shares Change (YoY) | +7.75% |
| Shares Change (QoQ) | +10.27% |
| Owned by Insiders (%) | 7.48% |
| Owned by Institutions (%) | 40.49% |
| Float | 27.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.88 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.86 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.92
| Current Ratio | 2.92 |
| Quick Ratio | 2.85 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -21.00% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -51.20% |
| Weighted Average Cost of Capital (WACC) | 17.65% |
| Revenue Per Employee | $266,264 |
| Profits Per Employee | -$710,604 |
| Employee Count | 106 |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.14% in the last 52 weeks. The beta is 2.97, so FHTX's price volatility has been higher than the market average.
| Beta (5Y) | 2.97 |
| 52-Week Price Change | +3.14% |
| 50-Day Moving Average | 4.70 |
| 200-Day Moving Average | 4.96 |
| Relative Strength Index (RSI) | 46.35 |
| Average Volume (20 Days) | 158,885 |
Short Selling Information
The latest short interest is 1.36 million, so 2.31% of the outstanding shares have been sold short.
| Short Interest | 1.36M |
| Short Previous Month | 1.38M |
| Short % of Shares Out | 2.31% |
| Short % of Float | 4.95% |
| Short Ratio (days to cover) | 10.56 |
Income Statement
In the last 12 months, FHTX had revenue of $28.22 million and -$75.32 million in losses. Loss per share was -$1.17.
| Revenue | 28.22M |
| Gross Profit | -53.88M |
| Operating Income | -80.77M |
| Pretax Income | -75.32M |
| Net Income | -75.32M |
| EBITDA | -78.02M |
| EBIT | -80.77M |
| Loss Per Share | -$1.17 |
Full Income StatementBalance Sheet
The company has $183.63 million in cash and $41.99 million in debt, with a net cash position of $141.64 million or $2.41 per share.
| Cash & Cash Equivalents | 183.63M |
| Total Debt | 41.99M |
| Net Cash | 141.64M |
| Net Cash Per Share | $2.41 |
| Equity (Book Value) | -76.41M |
| Book Value Per Share | -1.30 |
| Working Capital | 123.66M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$87.40 million and capital expenditures -$22,000, giving a free cash flow of -$87.42 million.
| Operating Cash Flow | -87.40M |
| Capital Expenditures | -22,000 |
| Depreciation & Amortization | 2.74M |
| Net Borrowing | n/a |
| Free Cash Flow | -87.42M |
| FCF Per Share | -$1.49 |
Full Cash Flow StatementMargins
Gross margin is -190.88%, with operating and profit margins of -286.16% and -266.88%.
| Gross Margin | -190.88% |
| Operating Margin | -286.16% |
| Pretax Margin | -266.88% |
| Profit Margin | -266.88% |
| EBITDA Margin | -276.45% |
| EBIT Margin | -286.16% |
| FCF Margin | n/a |
Dividends & Yields
FHTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.75% |
| Shareholder Yield | -7.75% |
| Earnings Yield | -30.04% |
| FCF Yield | -34.87% |
Analyst Forecast
The average price target for FHTX is $11.44, which is 167.92% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.44 |
| Price Target Difference | 167.92% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 38.81% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FHTX has an Altman Z-Score of -3.96 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.96 |
| Piotroski F-Score | 2 |
